AUSTIN, Texas, April 26, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its first quarter 2017 financial results on Thursday, May 11, 2017, followed by an investor conference call and webcast at 8:30 a.m. Eastern Time.
Thursday, May 11th @ 8:30am Eastern Time | |
Domestic: | 888-596-2629 |
International: | 913-312-0678 |
Conference ID: | 3158379 |
Webcast: | |
Replays, available through May 25th: | |
Domestic: | 844-512-2921 |
International: | 412-317-6671 |
Replay PIN: | 3158379 |
About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.
Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
Tel 1-646-597-6983
mwood@lifesciadvisors.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vermillion-to-report-first-quarter-2017-financial-results-and-host-investor-conference-call-on-may-11-300446520.html
SOURCE Vermillion, Inc.
